Prachi Bhave

1.0k total citations
22 papers, 298 citations indexed

About

Prachi Bhave is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Prachi Bhave has authored 22 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Prachi Bhave's work include Cancer Immunotherapy and Biomarkers (12 papers), Cutaneous Melanoma Detection and Management (9 papers) and Melanoma and MAPK Pathways (9 papers). Prachi Bhave is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Cutaneous Melanoma Detection and Management (9 papers) and Melanoma and MAPK Pathways (9 papers). Prachi Bhave collaborates with scholars based in Australia, United States and Germany. Prachi Bhave's co-authors include Andrew Haydon, Matteo S. Carlino, Douglas B. Johnson, Georgina V. Long, James R. Patrinely, Alexander M. Menzies, Fei Ye, Aleigha Lawless, Janice M. Mehnert and Amelia Sawyers and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Prachi Bhave

21 papers receiving 296 citations

Peers

Countries citing papers authored by Prachi Bhave

Since Specialization

Citations

This map shows the geographic impact of Prachi Bhave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prachi Bhave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prachi Bhave more than expected).

Fields of papers citing papers by Prachi Bhave

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prachi Bhave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prachi Bhave. The network helps show where Prachi Bhave may publish in the future.

Co-authorship network of co-authors of Prachi Bhave

This figure shows the co-authorship network connecting the top 25 collaborators of Prachi Bhave. A scholar is included among the top collaborators of Prachi Bhave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prachi Bhave. Prachi Bhave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase 1, first-in-human study of AMT-676, an anti-CDH17 antibody-drug conjugate, in patients with advanced gastrointestinal tumors. 2025 ·Journal of Clinical Oncology ·Charlotte Lemech, Warren Joubert, (unknown), Rui‐Hua Xu, (unknown), Prachi Bhave, (unknown), Yaling Huang, (unknown), Shu‐Hui Liu	1
2	Management of cutaneous melanoma in Australia: a narrative review 2023 ·The Medical Journal of Australia ·Prachi Bhave, J. Wong, Aideen McInerney‐Leo, Anne Ε. Cust, (unknown), Monika Janda, Victoria Mar	4
3	Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy 2023 ·Journal for ImmunoTherapy of Cancer ·Prachi Bhave, Angela Hong, Serigne Lo, (unknown), Johanna Mangana, Douglas B. Johnson, (unknown), Zeynep Eroglu, Hui‐Ling Yeoh, Andrew Haydon, Georg Lodde, Elisabeth Livingstone, Adnan Khattak, Katharina C. Kähler, (unknown), Grant A. McArthur, Alexander M. Menzies, Georgina V. Long, Wei Wang, Matteo S. Carlino	14
4	Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases 2021 ·European Journal of Cancer ·(unknown), Florentia Dimitriou, Peter K. H. Lau, Prachi Bhave, Grant A. McArthur, Lisa Zimmer, Ken Kudura, Camille L. Gérard, Mitchell P. Levesque, Olivier Michielin, Reinhard Dummer, Phil F. Cheng, Joanna Mangana	11
5	1047P Efficacy of checkpoint inhibitors (CPIs) in acral melanoma (AM) 2021 ·Annals of Oncology ·Prachi Bhave, Tasnia Ahmed, Alexander N. Shoushtari, Anne Zaremba, Judith M. Versluis, Joanna Mangana, Michael Weichenthal, Lu Si, Thierry Lesimple, Caroline Robert, Claudia Trojaniello, Alexandre Wicky, Richard Heywood, (unknown), (unknown), (unknown), Célèste Lebbé, Jürgen Schwarze, Meghan J. Mooradian, Matteo S. Carlino	3
6	Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti–PD-1 therapy 2021 ·European Journal of Cancer ·Adriana Hepner, Victoria Atkinson, James Larkin, Rebecca A. Burrell, Matteo S. Carlino, Douglas B. Johnson, Lisa Zimmer, Katy K. Tsai, Oliver Klein, Serigne Lo, Andrew Haydon, Prachi Bhave, Megan Lyle, Lalit Pallan, Inês Pires da Silva, Camille L. Gérard, Olivier Michielin, Georgina V. Long, Alexander M. Menzies	9
7	Management of resected stage III/IV melanoma with adjuvant immunotherapy. 2021 ·Journal of Clinical Oncology ·(unknown), Victoria Atkinson, Prachi Bhave, Alison M. Weppler, (unknown), (unknown), Megan Lyle, Muhammad Adnan Khattak, Andrew Haydon, Matteo S. Carlino, Shahneen Sandhu, Georgina V. Long, Alexander M. Menzies	0
8	Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma 2021 ·JAMA Oncology ·James R. Patrinely, (unknown), Aleigha Lawless, Prachi Bhave, Amelia Sawyers, (unknown), Hui‐Ling Yeoh, (unknown), Fei Ye, Run Fan, Elizabeth J. Davis, Suthee Rapisuwon, Georgina V. Long, Andrew Haydon, Iman Osman, Janice M. Mehnert, Matteo S. Carlino, Ryan J. Sullivan, Alexander M. Menzies, Douglas B. Johnson	152
9	Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders 2021 ·Journal for ImmunoTherapy of Cancer ·Lauren Brown, Alison M. Weppler, Prachi Bhave, Clara Allayous, James R. Patrinely, Patrick A. Ott, Shahneen Sandhu, Andrew Haydon, Célèste Lebbé, Douglas B. Johnson, Georgina V. Long, (unknown), Matteo S. Carlino	45
10	Efficacy of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy. 2021 ·Journal of Clinical Oncology ·Prachi Bhave, Angela Hong, (unknown), Alexander M. Menzies, Georgina V. Long, Joanna Mangana, Douglas B. Johnson, Zeynep Eroglu, (unknown), Hui‐Ling Yeoh, Andrew Haydon, (unknown), Elisabeth Livingstone, Muhammad Adnan Khattak, Katharina C. Kähler, Axel Hauschild, Wei Wang, Matteo S. Carlino	1
11	Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma 2020 ·Journal for ImmunoTherapy of Cancer ·Alison M. Weppler, Andrew Pattison, Prachi Bhave, (unknown), Jeanette Raleigh, Athena Hatzimihalis, Anthony J. Gill, Shiva Balachander, Jason Callahan, (unknown), George Au‐Yeung, Grant A. McArthur, Rodney J. Hicks, Richard W. Tothill, Shahneen Sandhu	8
12	1138P Delayed immune-related adverse events (irAEs) on anti-PD1-based therapy 2020 ·Annals of Oncology ·C. Owen, Xue Bai, Thuan Chong Quah, Serigne Lo, (unknown), Clara Martínez-Vila, Prachi Bhave, Irene L. M. Reijers, Camille L. Gérard, (unknown), Wen Xu, Sarah J. Welsh, Shahneen Sandhu, Joanna Mangana, Jennifer L. McQuade, Paolo A. Ascierto, Lisa Zimmer, Douglas B. Johnson, Célèste Lebbé, Alexander M. Menzies	2
13	1080MO The value of local therapy in treatment of solitary melanoma progression upon immune checkpoint inhibition 2020 ·Annals of Oncology ·Judith M. Versluis, (unknown), Alison M. Weppler, Lauren Brown, Karlijn de Joode, Karijn P.M. Suijkerbuijk, Lisa Zimmer, Ellen Kapiteijn, Clara Allayous, Douglas B. Johnson, Adriana Hepner, Joanna Mangana, Prachi Bhave, Yanina Jansen, Claudia Trojaniello, Victoria Atkinson, (unknown), Elisabeth G.E. de Vries, Christian U. Blank, Mathilde Jalving	1
14	Combination anti-PD-1 and ipilimumab (ipi) therapy in patients with advanced melanoma and pre-existing autoimmune disorders (AD). 2020 ·Journal of Clinical Oncology ·Lauren Brown, Alison M. Weppler, Prachi Bhave, Clara Allayous, James R. Patrinely, Patrick A. Ott, Shahneen Sandhu, Andrew Haydon, Célèste Lebbé, Douglas B. Johnson, Georgina V. Long, Alexander M. Menzies, Matteo S. Carlino	3
15	Activity and safety of third-line BRAF-targeted therapy (TT) following first-line TT and second-line immunotherapy (IT) in advanced melanoma. 2020 ·Journal of Clinical Oncology ·Victoria Atkinson, (unknown), Georgina V. Long, Matteo S. Carlino, (unknown), Prachi Bhave, (unknown), Wen Xu, Lauren Brown, (unknown), Megan Lyle, Alexander M. Menzies	3
16	Treatment of High Risk Resected Melanoma in Australia: Current Landscape and Practises 2020 ·Australasian Journal of Dermatology ·Prachi Bhave, Andrew Haydon	5
17	Melanoma recurrence after adjuvant targeted therapy: A multicenter analysis. 2020 ·Journal of Clinical Oncology ·Prachi Bhave, Lalit Pallan, Victoria Atkinson, Justine V. Cohen, Vanna Chiarion‐Sileni, Marta Nyakas, Katharina C. Kaehler, Elizabeth Ruth Plummer, Paolo A. Ascierto, Lisa Zimmer, Célèste Lebbé, Andrea Maurichi, Caroline Robert, Thierry Lesimple, Sapna P. Patel, Judith M. Versluis, Muhammad Adnan Khattak, André van der Westhuizen, Matteo S. Carlino, Andrew Haydon	3
18	The nature and management of acquired resistance to PD1-based therapy in melanoma. 2020 ·Journal of Clinical Oncology ·Adriana Hepner, Judith M. Versluis, Camille L. Gérard, Lauren Brown, Roslyn Wallace, Prachi Bhave, Yanina Jansen, Oliver Klein, Allison Betof Warner, Joanna Mangana, Victoria Atkinson, Serigne Lo, Georgina V. Long, Douglas B. Johnson, Jennifer L. McQuade, Paolo A. Ascierto, Lisa Zimmer, Célèste Lebbé, Christian U. Blank, Alexander M. Menzies	3
19	Intraperitoneal meropenem for peritoneal dialysis peritonitis with Serratia marcescens immediately on commencing dialysis 2016 ·New Microbes and New Infections ·Prachi Bhave, (unknown), Rowan G. Walker, Scott G. Wilson	6
20	A Guide to Performing Cardiac Surgery in Patients with Hereditary Bleeding Disorders 2014 ·Journal of Cardiac Surgery ·Prachi Bhave, David C. McGiffin, James W. Shaw, (unknown), (unknown), Huyen Tran, Amanda K. Davis	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact